Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Simulation-Based Interprofessional Education for Operating Room Teams

NCT07570134 · tracked via the Priya Life Science South Korea tracker
Phase
Not applicable
Started
2026-05-01
Last updated
2026-05-06

Condition(s) studied

Medical EducationInterprofessional RelationsPatient SafetyTeamwork

Investigational drug(s) / intervention(s)

Simulation-Based Interprofessional Education

Simulation-Based Interprofessional Education: The intervention consists of two 60-minute simulationbased interprofessional education sessions for operating room team members. Each session includes a representative operating room scenario and structured debriefing. Debriefing topics include role clarity, shared mental model, situational awareness, open communication, cross-monitoring, mutual respect, and application to clinical practice.

Study summary

This single-center, prospective, single-arm pilot study will evaluate a simulation-based interprofessional education program for early-career operating room team members at Yongin Severance Hospital. Participants will include postgraduate year 1-2 surgical residents, newly appointed anesthesia nurse practitioners, and newly appointed operating room nurses. Participants will complete two simulation-based interprofessional education sessions, each including scenario-based team training and structured debriefing. Teamwork self-efficacy and readiness for interprofessional learning will be assessed before and after the educational intervention. The study will also assess program completion as a feasibility outcome. Optional semi-structured interviews may be conducted to explore participants' perceptions of the program and suggestions for improvement.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Adults aged 19 years or older. * Affiliated with Yongin Severance Hospital and meeting one of the following criteria: * Postgraduate year 1-2 surgical resident; * Newly appointed anesthesia nurse practitioner with less than 6 months of experience in the relevant role; * Newly appointed operating room nurse with less than 6 months of operating room experience. * Able to participate in the planned study procedures during the study period. * Able and willing to provide written informed consent. Exclusion Criteria: * Individuals who do not provide written informed consent. * Individuals who are unable to complete the baseline or post-intervention questionnaires. * Individuals whose rotation, leave of absence, resignation, transfer, or work schedule change makes participation in the study procedures infeasible. * Individuals judged by the investigator to be inappropriate for study participation.

Primary outcome measure(s)

  • Change in teamwork selfefficacy score — Baseline and Week 7
    Teamwork self-efficacy will be assessed using a 15-item interprofessional teamwork selfefficacy questionnaire. Each item is scored on a 6-point Likert-type scale, with higher scores indicating greater confidence in team-based competencies. The outcome will be calculated as the change in total score from baseline to Week 7.

Trial sites (1)

FacilityCityRegionStatus
Yonsei University Yongin Severance Hospital Yongin-si Gyeonggi-do
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07570134 on ClinicalTrials.gov ↗ ← All trials in South Korea